{
  "disease_name": "Lymphoma",
  "synonyms": [
    "Malignant lymphoma",
    "Lymphoid malignancy"
  ],
  "summary": "Lymphoma is a group of blood cancers arising from lymphocytes, divided into Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). It commonly presents with painless lymphadenopathy and B symptoms; diagnosis is by lymph-node biopsy with immunophenotyping and staging by imaging.",
  "causes": [
    "Epstein–Barr virus (EBV) infection",
    "Human T-lymphotropic virus type 1 (HTLV-1) infection",
    "Chronic immune stimulation and autoimmune disease",
    "Immunosuppression (HIV/AIDS, post-transplant)",
    "Pesticide exposure",
    "Genetic and epigenetic alterations (e.g., BCL2, MYC, BCL6)"
  ],
  "risk_factors": [
    "HIV/AIDS",
    "Immunosuppressive therapy",
    "Autoimmune disease",
    "EBV infection",
    "HTLV-1 infection",
    "Older age",
    "Male sex",
    "Family history of lymphoma"
  ],
  "symptoms": [
    "Painless lymphadenopathy",
    "Fever",
    "Night sweats",
    "Unintended weight loss",
    "Pruritus",
    "Fatigue"
  ],
  "diagnosis": [
    "Excisional lymph-node biopsy",
    "Histopathology and immunophenotyping",
    "Flow cytometry",
    "FISH and cytogenetics",
    "CT and PET-CT for staging",
    "Bone marrow biopsy (selected cases)",
    "Ann Arbor staging"
  ],
  "treatments": [
    "Chemotherapy (e.g., CHOP)",
    "Immunochemotherapy (e.g., R-CHOP with rituximab)",
    "Radiation therapy",
    "Targeted therapy (BTK inhibitors, PI3K inhibitors, anti-CD20)",
    "CAR-T cell therapy (e.g., axi-cel, tisa-cel, liso-cel, brexu-cel)",
    "Stem cell transplant (autologous or allogeneic)",
    "Watchful waiting (indolent subtypes)"
  ],
  "related_genes": [
    "BCL2",
    "MYC",
    "BCL6",
    "TP53",
    "CARD11",
    "MYD88",
    "EZH2",
    "CCND1",
    "ALK"
  ],
  "subtypes": [
    {
      "name": "Hodgkin lymphoma",
      "typical_patients": "Young adults and older adults (bimodal)",
      "five_year_survival": "≈85% (US)",
      "common_treatments": [
        "ABVD chemotherapy",
        "Radiation therapy",
        "Brentuximab vedotin (selected)",
        "PD-1 inhibitors (relapsed)"
      ]
    },
    {
      "name": "Diffuse large B-cell lymphoma (DLBCL)",
      "typical_patients": "Older adults; aggressive",
      "five_year_survival": "≈60–70% (stage-dependent)",
      "common_treatments": [
        "R-CHOP",
        "Radiation therapy (selected)",
        "CAR-T (relapsed)"
      ]
    },
    {
      "name": "Follicular lymphoma",
      "typical_patients": "Middle-aged to older adults; indolent",
      "five_year_survival": "≈85–90%",
      "common_treatments": [
        "Watchful waiting",
        "Rituximab ± chemotherapy",
        "Radiation therapy (localized)"
      ]
    },
    {
      "name": "Mantle cell lymphoma",
      "typical_patients": "Older men; t(11;14) CCND1 overexpression",
      "five_year_survival": "≈60%",
      "common_treatments": [
        "Immunochemotherapy",
        "BTK inhibitors",
        "Stem cell transplant (selected)"
      ]
    },
    {
      "name": "Burkitt lymphoma",
      "typical_patients": "Children and young adults; EBV-associated in endemic regions",
      "five_year_survival": "≈80–90% with intensive therapy",
      "common_treatments": [
        "Intensive multi-agent chemotherapy",
        "Rituximab"
      ]
    }
  ],
  "epidemiology": {
    "global_cases_2015": "566000",
    "global_deaths_2015": "305000",
    "most_common_in": "More frequent in developed countries; NHL ~90% of cases",
    "five_year_survival_rate": "US: HL ≈85%, NHL ≈69%"
  },
  "relationships": [
    {
      "source": "Lymphoma",
      "relation": "has_symptom",
      "target": "Painless lymphadenopathy"
    },
    {
      "source": "Lymphoma",
      "relation": "has_symptom",
      "target": "Night sweats"
    },
    {
      "source": "Lymphoma",
      "relation": "has_symptom",
      "target": "Fever"
    },
    {
      "source": "Lymphoma",
      "relation": "has_symptom",
      "target": "Weight loss"
    },
    {
      "source": "Lymphoma",
      "relation": "has_risk_factor",
      "target": "HIV/AIDS"
    },
    {
      "source": "Lymphoma",
      "relation": "has_risk_factor",
      "target": "Immunosuppressive therapy"
    },
    {
      "source": "Lymphoma",
      "relation": "has_risk_factor",
      "target": "EBV infection"
    },
    {
      "source": "Lymphoma",
      "relation": "has_cause",
      "target": "HTLV-1 infection"
    },
    {
      "source": "Lymphoma",
      "relation": "associated_gene",
      "target": "BCL2"
    },
    {
      "source": "Lymphoma",
      "relation": "associated_gene",
      "target": "MYC"
    },
    {
      "source": "Lymphoma",
      "relation": "associated_gene",
      "target": "BCL6"
    },
    {
      "source": "Lymphoma",
      "relation": "treated_with",
      "target": "R-CHOP"
    },
    {
      "source": "Lymphoma",
      "relation": "treated_with",
      "target": "Radiation therapy"
    },
    {
      "source": "Lymphoma",
      "relation": "treated_with",
      "target": "CAR-T cell therapy"
    },
    {
      "source": "Hodgkin lymphoma",
      "relation": "subtype_of",
      "target": "Lymphoma"
    },
    {
      "source": "Diffuse large B-cell lymphoma",
      "relation": "subtype_of",
      "target": "Lymphoma"
    },
    {
      "source": "Follicular lymphoma",
      "relation": "subtype_of",
      "target": "Lymphoma"
    },
    {
      "source": "Mantle cell lymphoma",
      "relation": "subtype_of",
      "target": "Lymphoma"
    },
    {
      "source": "Burkitt lymphoma",
      "relation": "subtype_of",
      "target": "Lymphoma"
    }
  ]
}